APA (7th ed.) Citation

Srimongkol, A., Laosillapacharoen, N., Saengwimol, D., Chaitankar, V., Rojanaporn, D., Thanomchard, T., . . . Kaewkhaw, R. (2023). Sunitinib efficacy with minimal toxicity in patient-derived retinoblastoma organoids. Journal of Experimental & Clinical Cancer Research (17569966), 42(1), 1. https://doi.org/10.1186/s13046-023-02608-1

Chicago Style (17th ed.) Citation

Srimongkol, Atthapol, Natanan Laosillapacharoen, Duangporn Saengwimol, Vijender Chaitankar, Duangnate Rojanaporn, Thanastha Thanomchard, Suparerk Borwornpinyo, Suradej Hongeng, and Rossukon Kaewkhaw. "Sunitinib Efficacy with Minimal Toxicity in Patient-derived Retinoblastoma Organoids." Journal of Experimental & Clinical Cancer Research (17569966) 42, no. 1 (2023): 1. https://doi.org/10.1186/s13046-023-02608-1.

MLA (9th ed.) Citation

Srimongkol, Atthapol, et al. "Sunitinib Efficacy with Minimal Toxicity in Patient-derived Retinoblastoma Organoids." Journal of Experimental & Clinical Cancer Research (17569966), vol. 42, no. 1, 2023, p. 1, https://doi.org/10.1186/s13046-023-02608-1.